Your email has been successfully added to our mailing list.

×
0.0103761348897536 0.0265758754863814 0.00778210116731524 0.0168612191958496 -0.020752269779507 0.040207522697795 0.0499351491569391 0.0959792477302206
Stock impact report

Abeona down 17% on delay of late-stage study of EB-101 in RDEB [Seeking Alpha]

Abeona Therapeutics Inc. (ABEO) 
Last abeona therapeutics inc. earnings: 3/16 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.abeonatherapeutics.com
Company Research Source: Seeking Alpha
Abeona Therapeutics ( ABEO ) is down on 70% higher volume in apparent response to an extended timeline for the start of a Phase 3 clinical trial evaluating autologous cell therapy EB-101 in patients with recessive dystrophic epidermolysis bullosa (RDEB), the most severe type of EB. Management had said that the study would launch in the second half of this year but now expects it to start in 2019 while CMC work and comparability studies are completed. See all stocks on the move » Now read: Oncolytics Biotech (ONCY) Investor Presentation - Slideshow » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
ABEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ABEO alerts

from News Quantified
Opt-in for
ABEO alerts

from News Quantified